Literature DB >> 22855807

Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator.

Harry J Han1, Carolyn C Allen, Christie M Buchovecky, Michael J Yetman, Heather A Born, Miguel A Marin, Shaefali P Rodgers, Bryan J Song, Hui-Chen Lu, Monica J Justice, Frank J Probst, Joanna L Jankowsky.   

Abstract

The tet-off system has been widely used to create transgenic models of neurological disorders including Alzheimer's, Parkinson's, Huntington's, and prion disease. The utility of this system lies in the assumption that the tetracycline transactivator (TTA) acts as an inert control element and does not contribute to phenotypes under study. Here we report that neuronal expression of TTA can affect hippocampal cytoarchitecture and behavior in a strain-dependent manner. While studying neurodegeneration in two tet-off Alzheimer's disease models, we unexpectedly discovered neuronal loss within the dentate gyrus of single transgenic TTA controls. Granule neurons appeared most sensitive to TTA exposure during postnatal development, and doxycycline treatment during this period was neuroprotective. TTA-induced degeneration could be rescued by moving the transgene onto a congenic C57BL/6J background and recurred on reintroduction of either CBA or C3H/He backgrounds. Quantitative trait analysis of B6C3 F2 TTA mice identified a region on Chromosome 14 that contains a major modifier of the neurodegenerative phenotype. Although B6 mice were resistant to degeneration, they were not ideal for cognitive testing. F1 offspring of TTA C57BL/6J and 129X1/SvJ, FVB/NJ, or DBA/1J showed improved spatial learning, but TTA expression caused subtle differences in contextual fear conditioning on two of these backgrounds, indicating that strain and genotype can interact independently under different behavioral settings. All model systems have limitations that should be recognized and mitigated where possible; our findings stress the importance of mapping the effects caused by TTA alone when working with tet-off models.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855807      PMCID: PMC3431916          DOI: 10.1523/JNEUROSCI.0893-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

1.  Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

Authors:  A Yamamoto; J J Lucas; R Hen
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.

Authors:  J Lewis; E McGowan; J Rockwood; H Melrose; P Nacharaju; M Van Slegtenhorst; K Gwinn-Hardy; M Paul Murphy; M Baker; X Yu; K Duff; J Hardy; A Corral; W L Lin; S H Yen; D W Dickson; P Davies; M Hutton
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

3.  In vivo olfactory model of APP-induced neurodegeneration reveals a reversible cell-autonomous function.

Authors:  Ning Cheng; Huaibin Cai; Leonardo Belluscio
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

4.  Genealogies of mouse inbred strains.

Authors:  J A Beck; S Lloyd; M Hafezparast; M Lennon-Pierce; J T Eppig; M F Festing; E M Fisher
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

5.  A GFP-equipped bidirectional expression module well suited for monitoring tetracycline-regulated gene expression in mouse.

Authors:  H E Krestel; M Mayford; P H Seeburg; R Sprengel
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

6.  Tau filament formation in transgenic mice expressing P301L tau.

Authors:  J Götz; F Chen; R Barmettler; R M Nitsch
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

7.  CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy.

Authors:  M Cecilia Ljungberg; Yousuf O Ali; Jie Zhu; Chia-Shan Wu; Kazuhiro Oka; R Grace Zhai; Hui-Chen Lu
Journal:  Hum Mol Genet       Date:  2011-10-25       Impact factor: 6.150

8.  Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids.

Authors:  E E Schmidt; D S Taylor; J R Prigge; S Barnett; M R Capecchi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

9.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.

Authors:  Denise Harold; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Marian L Hamshere; Jaspreet Singh Pahwa; Valentina Moskvina; Kimberley Dowzell; Amy Williams; Nicola Jones; Charlene Thomas; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; John Hardy; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Hendrik van den Bussche; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Kristel Sleegers; Karolien Bettens; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panagiotis Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Magda Tsolaki; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; Peter A Holmans; Michael O'Donovan; Michael J Owen; Julie Williams
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330

10.  Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.

Authors:  Xian Lin; Loukia Parisiadou; Xing-Long Gu; Lizhen Wang; Hoon Shim; Lixin Sun; Chengsong Xie; Cai-Xia Long; Wan-Jou Yang; Jinhui Ding; Zsu Zsu Chen; Paul E Gallant; Jung-Hwa Tao-Cheng; Gay Rudow; Juan C Troncoso; Zhihua Liu; Zheng Li; Huaibin Cai
Journal:  Neuron       Date:  2009-12-24       Impact factor: 17.173

View more
  46 in total

1.  The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer's disease.

Authors:  Megan M Varnum; Tomomi Kiyota; Kaitlin L Ingraham; Seiko Ikezu; Tsuneya Ikezu
Journal:  Neurobiol Aging       Date:  2015-08-01       Impact factor: 4.673

2.  Impairments in experience-dependent scaling and stability of hippocampal place fields limit spatial learning in a mouse model of Alzheimer's disease.

Authors:  Rong Zhao; Stephanie W Fowler; Angie C A Chiang; Daoyun Ji; Joanna L Jankowsky
Journal:  Hippocampus       Date:  2014-05-05       Impact factor: 3.899

3.  Transcriptional signatures of brain aging and Alzheimer's disease: What are our rodent models telling us?

Authors:  Kendra E Hargis; Eric M Blalock
Journal:  Behav Brain Res       Date:  2016-05-04       Impact factor: 3.332

4.  Cerebellar contribution to the cognitive alterations in SCA1: evidence from mouse models.

Authors:  Melissa Asher; Juao-Guilherme Rosa; Orion Rainwater; Lisa Duvick; Michael Bennyworth; Ruo-Yah Lai; Sheng-Han Kuo; Marija Cvetanovic
Journal:  Hum Mol Genet       Date:  2020-01-01       Impact factor: 6.150

5.  Differential Neurotoxicity Related to Tetracycline Transactivator and TDP-43 Expression in Conditional TDP-43 Mouse Model of Frontotemporal Lobar Degeneration.

Authors:  L Kukreja; R Shahidehpour; G Kim; J Keegan; K R Sadleir; T Russell; J Csernansky; M Mesulam; R J Vassar; L Wang; H Dong; C Geula
Journal:  J Neurosci       Date:  2018-05-28       Impact factor: 6.167

6.  Alterations of functional circuitry in aging brain and the impact of mutated APP expression.

Authors:  Elaine L Bearer; Brett C Manifold-Wheeler; Christopher S Medina; Aaron G Gonzales; Frances L Chaves; Russell E Jacobs
Journal:  Neurobiol Aging       Date:  2018-06-28       Impact factor: 4.673

7.  Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex.

Authors:  Michael J Yetman; Sveinung Lillehaug; Jan G Bjaalie; Trygve B Leergaard; Joanna L Jankowsky
Journal:  Brain Struct Funct       Date:  2015-04-14       Impact factor: 3.270

8.  Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.

Authors:  Julia E Gamache; Lisa Kemper; Elizabeth Steuer; Kailee Leinonen-Wright; Jessica M Choquette; Chris Hlynialuk; Kellie Benzow; Keith A Vossel; Weiming Xia; Michael D Koob; Karen H Ashe
Journal:  J Neurosci       Date:  2019-11-04       Impact factor: 6.167

9.  Sex-related dimorphism in dentate gyrus atrophy and behavioral phenotypes in an inducible tTa:APPsi transgenic model of Alzheimer's disease.

Authors:  Tatiana Melnikova; DaMin Park; Lauren Becker; Deidre Lee; Eugenia Cho; Nuzhat Sayyida; Jing Tian; Karen Bandeen-Roche; David R Borchelt; Alena V Savonenko
Journal:  Neurobiol Dis       Date:  2016-08-26       Impact factor: 5.996

10.  Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis.

Authors:  Tatiana Melnikova; Susan Fromholt; HyunSu Kim; Deidre Lee; Guilian Xu; Ashleigh Price; Brenda D Moore; Todd E Golde; Kevin M Felsenstein; Alena Savonenko; David R Borchelt
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.